Scholars@Duke

Anti-PD1 in combination with an inhibitor of PCSK9 to increase MHC class I molecule expression on tumor cells as immunotherapy for NSCLC

Clinical Trial Grant
Duke Scholars
Xiaofei Wang
Biostatistician Xiaofei Wang Biostatistics & Bioinformatics, Division of Biostatistics
Michael John Kelley
Co Investigator Michael John Kelley Medicine, Medical Oncology
Andrew Benjamin Nixon
Co Investigator Andrew Benjamin Nixon Medicine, Medical Oncology
Kouros Owzar
Director Kouros Owzar Biostatistics & Bioinformatics, Division of Integrative Geno ...
Pixu Shi
Biostatistician Pixu Shi Biostatistics & Bioinformatics, Division of Integrative Geno ...
Scott Joseph Antonia
Principal Investigator Scott Joseph Antonia Medicine, Medical Oncology
Kent James Weinhold
Laboratory Director Kent James Weinhold Surgery, Surgical Sciences

Administered By

Medicine, Medical Oncology

Awarded By

Department of Defense

Start Date

June 15, 2021

End Date

June 14, 2025
 

Administered By

Medicine, Medical Oncology

Awarded By

Department of Defense

Start Date

June 15, 2021

End Date

June 14, 2025